Practical Considerations for Integrating GLP-1RA and SGLT2i Into Practice When using these classes for cardiorenal benefit, one must consider potential side effects and advise on strategies to minimize them (Table 4 and Fig
Although reducing energy intake supports weight loss, it can be harder to ensure you stay well-nourished while on a GLP-1 medication
Jan 16, 2026 11 min read READ MORE
This review follows NNCs Price & Trust Transparency Score methodology, which evaluates providers across true cost analysis and safety & legitimacy
Medicare prescription plans do not cover weight-loss medications, although they often cover Wegovy and Zepbound for other FDA-approved purposes, such as treating obstructive sleep apnea (Zepbound) or lowering the risk of major cardiovascular events (Wegovy)
LEADER trial: Cardiovascular outcomes with liraglutide JAMA Network Open (2022)